Overview
International law firm McDermott Will & Emery represented WindRose Health Investors, LLC, a New York-based healthcare private equity firm, in the debt financing and recapitalization of RevHealth, LLC, one of the largest independent providers of omnichannel healthcare communications to the life sciences industry. Following WindRose’s investment, RevHealth is well-positioned to further accelerate its rapid growth, drawing on WindRose’s extensive experience investing in innovative pharmaceutical services companies.
- The transaction was announced on July 27, 2022.
- McDermott deal team was led by Ira Coleman, Krist Werling and Jarrett Szczesny and included Nicole Yoon, Matt Celano, Jacob Hollinger, James Cannatti, Jeffrey Holdvogt, Alex Ruiz, David Neville, Gregory Heltzer, Sarah Bro, Michelle Strowhiro, Anisa Mohanty, Sam Neel, Jaiyan Chen, Ty Carson, Ryan Smethurst, Verneessa Pollard, Emily Mussio, Marchan Clark, Simone Hussussian, Melis Solaksubasi, Kate Williams, Harrison Farmer, Deepali Doddi, Abigail Kagan, Graham Hyman and Cristell Fortune. The debt financing team included Joshua Samis, Riley Orloff and Max Brady.
- Read Windrose’s press release here.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
